enVista Envy IOLs will be commercially available in the U.S. on a limited basis in the coming weeks and more broadly in 2025. Bausch + Lomb is also in the process of seeking regulatory approvals for ...
AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency and control
Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at ...
GlobalData on MSN21h
Bausch + Lomb wins FDA nod for enVista Envy range of intraocular lensesThe approval comes amidst rumours of a potential private equity buyout of the Canadian company, whose parent company has ...
The Healthy on MSN8h
“What I Wish I’d Known About Cataract Surgery”: A Doctor Details What Patients Should Know About a Common ProcedureWhat are the signs that show I need cataract surgery? "There are several key signs that someone may need cataract surgery," ...
The FDA granted approval to the enVista Envy full range of vision IOLs following Canadian approval in May 2024.
IOL Chemicals and Pharmaceuticals Ltd., incorporated in the year 1986, is a Small Cap company (having a market cap of Rs 2,516.12 Crore) operating in Pharmaceuticals sector. IOL Chemicals and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback